Daniel Galera Bernabé

Daniel Galera Bernabé

Auto-generated profile, based on publicly available information

Daniel Galera Bernabé

Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
DBDaniel G. Bernabé
Daniel G. Bernabé
ATAdriano C. Tamae
Adriano C. Tamae
ÉBÉder R. Biasoli
Éder R. Biasoli
SOSandra H.P. Oliveira
Sandra H.P. Oliveira

25 June 2012 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
DBDaniel Galera Bernabé
Daniel Galera Bernabé
ATAdriano Caires Tamae
Adriano Caires Tamae
GMGlauco Issamu Miyahara
Glauco Issamu Miyahara
MSMaria Lúcia Marçal Sundefeld
Maria Lúcia Marçal Sundefeld
SOSandra Penha Oliveira
Sandra Penha Oliveira
ÉBÉder Ricardo Biasoli
Éder Ricardo Biasoli
Objectives Dysregulation of the hypothalamus–pituitary–adrenal axis has been observed in patients with cancer. This cross-sectional study investigated whether patients with oral and oropharyngeal squamous cell carcinoma (SCC) show changes in cortisol levels in saliva and plasma compared with three control groups, and evaluated its correlation with clinicopathological data. Methods Salivary and plasma cortisol levels of 34 patients with oral SCC were compared with hormonal levels of 17 oropharyngeal SCC patients, 17 oral leukoplakia patients, 27 smokers and/or drinkers and 25 healthy volunteers. Multivariate analysis was used to evaluate the impact of clinical variables on the cortisol levels. Results The plasma (p<0.05) and salivary (p<0.01) cortisol levels were significantly higher in patients with oral SCC compared with all groups. Patients with oropharyngeal SCC had higher levels of salivary cortisol compared with smokers and/or drinkers (p<0.05) and patients with leukoplakia (p<0.01). Patients with advanced-stage oral SCC showed significantly higher levels of cortisol than those in an initial clinical stage. Men with oral SCC had higher salivary cortisol levels than women (p<0.05). Age, smoking, alcohol consumption, presence of teeth and awareness of cancer diagnosis had no significant effect on cortisol levels. Conclusions These results indicate a dysregulation of cortisol secretion in patients with oral cancer and suggest that this hormone can be a biomarker associated with the disease's clinical status.

5 June 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
YYYi Ye
Yi Ye
KOKentaro Ono
Kentaro Ono
DBDaniel G Bernabé
Daniel G Bernabé
CVChi T Viet
Chi T Viet
VPVictoria Pickering
Victoria Pickering
BSBrian Schmidt
Brian Schmidt
Cancer pain creates a poor quality of life and decreases survival. The basic neurobiology of cancer pain is poorly understood. Adenosine triphosphate (ATP) and the ATP ionotropic receptor subunits, P2X2 and P2X3, mediate cancer pain in animal models; however, it is unknown whether this mechanism operates in human, and if so, what the relative contribution of P2X2- and P2X3-containing trimeric channels to cancer pain is. Here, we studied head and neck squamous cell carcinoma (HNSCC), which causes the highest level of function-induced pain relative to other types of cancer.

1 June 2016 in Journal of Endodontics
Verified
Journal Article
Closed access
ATAline Satie Takamiya
Aline Satie Takamiya
DMDouglas Monteiro
Douglas Monteiro
DBDaniel Galera Bernabé
Daniel Galera Bernabé
Luiz Fernando GorupLuiz Fernando Gorup
Luiz Fernando Gorup
ECEmerson Camargo
Emerson Camargo
DBDebora Barros Barbosa
Debora Barros Barbosa

15 October 2021 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DBDaniel G. Bernabé
Daniel G. Bernabé
Catecholamines, which are involved in response to physical or emotional stress, have emerged as one of the main mediators of the relationship between chronic stress and cancer progression. The study in this issue of Cancer Research by Liu and colleagues reveals a new mechanism by which psychologic stress stimulates cancer progression through the D2 dopamine receptor and activation of the oxygen-independent HIF1α pathway. Although most investigations so far have focused on the action of the stress-related catecholamines norepinephrine and epinephrine on tumor cells, this study shows that dopamine and its receptor can be a potential therapeutic target. The findings broaden the understanding of the interaction of catecholamines with the tumor microenvironment and reinforces the need to look at psychologic stress as a modulator of cancer progression. See related article by Liu et al., p. 5353

1 July 2016 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
ÉBÉder Ricardo Biasoli
Éder Ricardo Biasoli
VVVitor Bonetti Valente
Vitor Bonetti Valente
BMBruna Mantovan
Bruna Mantovan
FCFrancisco Urbano Collado
Francisco Urbano Collado
SNSebastião Conrado Neto
Sebastião Conrado Neto
DBDaniel Galera Bernabé
Daniel Galera Bernabé
There are few clinical studies focusing on treatment outcomes of lip cancer. This study investigated the clinicopathologic variables of a large sample of patients with lip squamous cell carcinoma (LSCC) treated in a reference head and neck cancer center for the past 25 years and analyzed the influence of these variables on treatment outcomes. This retrospective cohort study reviewed the clinical records of patients with LSCC. Epidemiologic data were age, gender, ethnicity, type of occupation, tobacco smoking, alcohol consumption, comorbid conditions, and family cancer history. Clinicopathologic features included the lip location of the tumor, TNM classification, clinical staging, histopathologic grade, surgical margin analysis, and treatment modality. Local recurrence, second primary tumor, and survival were the outcome variables. Statistical analysis was performed by χ(2) test, Fisher exact test, and binary logistic regression analysis. Survival analysis was assessed through the Kaplan-Meier curve. Level of statistical significance was set at a P value less than .05 for all tests. In total, 144 patients with LSCC were studied. There were 117 men (81.25%) and 27 women (18.75%) with a mean age of 60.21 years. One hundred thirty-four patients (93.05%) were considered of white ethnicity, and in 57 cases (39.58%), the patients reported an occupation that was related to long-term solar exposure. Most cancers had initial clinical staging of 1 or 2 (84.02%). Microscopically, lesions were predominantly well (43.05%) and moderately (40.96%) differentiated tumors. Clinical staging was related to a specific higher survival rate (P = .0049). One hundred twelve cases (77.78%) underwent surgical treatment and only 6 patients (4.80%) had local recurrence, which was directly associated with compromised surgical margins (P = .0320). A high success rate in LSCC treatment was observed in this study. Compromised surgical margin was associated with tumor recurrence and is a critical event in lip cancer treatment.